Hemab Therapeutics Holdings, Inc. Balance Sheet
Hemab Therapeutics Holdings, Inc.'s total assets for Q2 2026 were $467.78M, an increase of 166.91% from the previous quarter. COAG total liabilities were $13.51M for the fiscal quarter, a -96.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
